Also trades as: RVV.CN (CNQ) · $vol 0M
RVVTF OTC
Revive Therapeutics Ltd.
1W: +26.1%
1M: +15.4%
3M: -2.3%
YTD: +128.3%
1Y: +97.2%
3Y: -38.2%
5Y: -94.5%
$0.02
+0.00 (+16.67%)
Weekly Expected Move ±21.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$768K
+76.7% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$768K
+76.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$759K
+42.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$20M | -$18M | -$6M | -$6M | -$11M |
| Depreciation & Amort. | $775 | $578 | $434 | $328 | $248 |
| Stock-Based Comp. | $9M | $1M | $0 | $136K | $124K |
| Change in Working Capital | $706K | $4M | -$748K | -$186K | $603K |
| Other Non-Cash Items | $3M | $138K | $1M | $2M | $10M |
| Operating Cash Flow | -$8M | -$13M | -$6M | -$3M | -$768K |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | -$30K |
| Investment Sales | $281K | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$3M | $0 | $0 | $0 | -$30K |
| — Financing Activities — | |||||
| Net Debt Issuance | $21K | $202 | -$152K | -$40K | $39K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$2M | $0 | $443K | $0 | $0 |
| Financing Cash Flow | $26M | $376K | $4M | $2M | $39K |
| Net Change in Cash | $15M | -$13M | -$2M | -$1M | -$759K |
| Cash End of Period | $17M | $4M | $2M | $773K | $15K |
| Free Cash Flow | -$11M | -$13M | -$6M | -$3M | -$768K |